UNSPSC 51422363: Prednisolone sodium metasulfobenzoate

This classification denotes a therapeutic glucocorticoid with the molecular formula C28H31O9S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D345THM53T, chemically known as pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-((3-sulfobenzoyl)oxy)-, sodium salt (1:1), (11.beta.)-, but more generally known as prednisolone sodium metasulfobenzoate, which bears US NIH Compound Identifier 12421.

UNSPSC 51422363 Prednisolone sodium metasulfobenzoate is a Commodity code that in practice does not align with recent state and local solicitation activity. The code nominally describes a specific corticosteroid pharmaceutical product, but the two recent opportunities tagged to this code — Seminole County's procurement of naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's request for information on direct-to-manufacturer prescription programs — involve entirely different product categories and procurement models. Naloxone is an opioid antagonist unrelated to prednisolone, and the Texas RFI addresses pharmacy benefit program administration and direct contracting with manufacturers rather than procurement of a single pharmaceutical commodity. State and local activity under this code shows little relevant recent momentum for prednisolone sodium metasulfobenzoate specifically.

The mismatch between the code's nominal scope and actual purchasing patterns suggests that either the source data contains tagging errors or this particular commodity sees minimal state and local government demand sufficient to trigger direct solicitation. Seminole County and the Texas HHS Commission represent health system and pharmacy administration buyers, jurisdictions that would purchase pharmaceuticals through existing formularies, group purchasing agreements, or vendor management platforms rather than standalone IFBs or RFIs for a single pharmaceutical ingredient. Without recent opportunities that actually target prednisolone sodium metasulfobenzoate procurement, the code offers no clear signal of current market activity or buying patterns in state and local procurement.